Neuroendovascular Treatment of Acute Stroke During COVID-19: A Guide From the Frontlines

Cox, Mougnyan; Ramchand, Preethi; Mccabe, M. J.; Hoey, Colin; Lehmann, Jessica; Collinson, Randi L.; Kung, David; Pukenas, Bryan; Thacker, Ike; Layton, Kennith F.; Hurst, Robert W.; Sedora‐Roman, Neda I.

doi:10.1016/j.jradnu.2020.05.007

Cited by 2 publications

(4 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Standard acute stroke treatment guidelines need to be followed in the management of patients with acute stroke, regardless of SARS-CoV-2 infection [ 139 , 140 ]. An individualized decision may have to be taken in patients with severe SARS-CoV-2 infection.…”

Section: Cns Manifestations Associated With Covid-19mentioning

confidence: 99%

Central Nervous System Manifestations Associated with COVID-19

Divani

Andalib

Biller

et al. 2020

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

Purpose of Review Coronavirus disease 2019 (COVID-19) has become a global health crisis of our time. The disease arises from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that binds to angiotensin-converting enzyme 2 (ACE2) receptors on host cells for its internalization. COVID-19 has a wide range of respiratory symptoms from mild to severe and affects several other organs, increasing the complexity of the treatment. There is accumulating evidence to suggest that SARS-CoV-2 can target the nervous system. In this review, we provide an account of the COVID-19 central nervous system (CNS) manifestations. Recent Findings A broad spectrum of the CNS manifestations including headache, impaired consciousness, delirium, loss of smell and taste, encephalitis, seizures, strokes, myelitis, acute disseminated encephalomyelitis, neurogenic respiratory failure, encephalopathy, silent hypoxemia, generalized myoclonus, neuroleptic malignant syndrome and Kawasaki syndrome has been reported in patients with COVID-19. Summary CNS manifestations associated with COVID-19 should be considered in clinical practice. There is a need for modification of current protocols and standing orders to provide better care for COVID-19 patients presenting with neurological symptoms.

show abstract

Section: Cns Manifestations Associated With Covid-19mentioning

confidence: 99%

Central Nervous System Manifestations Associated with COVID-19

Divani

Andalib

Biller

et al. 2020

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

show abstract

“… Al Kasab S; North and South America, Europe [ 45 ] Good Good Good Good Good Good Good Good Good 2. Cox M, USA [ 46 ] Good Good Fair Fair Fair Good Good Good Good 3. Escalard E, France [ 47 ] Good Good Good Good Fair Good Good Good Good 4.…”

Section: Main Text (Review Of the Literature Results Discussion)mentioning

confidence: 99%

“… 2. Cox M, USA [ 46 ] Cross-sectional 45 PCS in MT of AIS patients The importance of PCS implementation and the use of PPE during MT. 3.…”

Section: Main Text (Review Of the Literature Results Discussion)mentioning

confidence: 99%

“…PCS is the modified of regular code stroke during the COVID-19 pandemic to provide an additional layer of protection (including PPE) for patients and medical personnel who were engaged in triage, rapid assessment, COVID-19 screening, and treatment of patients [ 30 ]. Cox and colleagues (2020), Mansour and colleagues (2020), Yaeger and colleagues (2020), and Yeboah and colleagues (2020) and reported about the importance of healthcare worker to follow PCS algorithm and the use of appropriate PPE to reduce the risk of COVID-19 infection [ 46 , 50 , 55 , 56 ].…”

Section: Main Text (Review Of the Literature Results Discussion)mentioning

confidence: 99%

See 1 more Smart Citation

Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in COVID-19 pandemic: a systematic review

Kurnianto

Tugasworo

Andhitara

et al. 2021

Egypt J Neurol Psychiatry Neurosurg

View full text Add to dashboard Cite

Introduction Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Initially, COVID-19 is a disease that attacks the respiratory tract, but now the clinical manifestations of COVID-19 are various, including acute ischemic stroke (AIS). Emergency surgeries such as mechanical thrombectomy (MT) for AIS must be performed without any delay even during the COVID-19 pandemic, to reduce morbidity and mortality. Besides the focus on patient’s health, the safety of healthcare workers must also be considered. The aim of the study was to evaluate and summarize the scientific literature systematically to explore MT for AIS in the COVID-19 pandemic. Data synthesis The independent reviewers searched the literature through 12 electronic databases, searching for articles fulfilling inclusion and exclusion criteria. The data from all included studies were presented in a summary table featuring key points of each study. The authors independently assessed the risk of bias of 15 included articles. Conclusion Although MT procedure has been prolonged during the pandemic, clinical outcomes and procedure-related serious adverse events have remained unchanged during the COVID-19 pandemic. The screening process and the implementation of the PCS algorithm must be performed to reduce the spread of COVID-19 infection without threatening patient safety and clinical outcomes. The standard precaution of infection and the health assurance of healthcare workers and their families (including mental health) are also important factors that must be given special attention and consideration in the COVID-19 pandemic.

show abstract

Neuroendovascular Treatment of Acute Stroke During COVID-19: A Guide From the Frontlines

Cited by 2 publications

References 7 publications

Central Nervous System Manifestations Associated with COVID-19

Central Nervous System Manifestations Associated with COVID-19

Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in COVID-19 pandemic: a systematic review

Contact Info

Product

Resources

About